CCL17 is involved in the induction or enhancement of a broad spectrum of immune reactions, ranging from contact hypersensitivity responses and allograft rejection to inflammatory bowel disease and various inflammatory diseases, such as atopic dermatitis and atherosclerosis [47,49,50,54]. Here, CCL17 is linked to atherosclerosis.